Skip to main content
Annals of Surgery logoLink to Annals of Surgery
. 1985 Jul;202(1):98–103. doi: 10.1097/00000658-198507000-00016

Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator.

J W Kelly, R W Sagebiel, S Clyman, M S Blois
PMCID: PMC1250844  PMID: 4015217

Abstract

A small proportion of "thin" malignant melanomas will metastasize and cause death. To assess the role of discordance between the major indicators of tumor depth (thickness and level) as a possible explanation for this phenomenon, prognosis by level has been examined in 255 cases, with tumors ranging in thickness from 0.6 to 1.1 mm. This is the range of thickness at which levels II, III, and IV overlap. The 5-year survival rate of patients with level IV tumors in this thickness range (59.35%) was poor (p less than 0.0001), relative to that of patients with level II (96.8%) and III (94.49%) lesions in the same range of tumor thickness. The distributions of other major prognostic indicators, among the groups of patients with tumors at each level, were examined to assess the possible contribution of factors other than level to the differences in survival between the three groups. These differences in survival could not be attributed to differing distributions of tumor thickness, tumor location, or patient sex. Of six prognostic variables, examined by Cox multivariate regression analysis, for tumors of thickness 0.6 to 1.1 mm, only level was found to have independent prognostic significance (p = 0.0025). The thin level IV melanoma appears to be an important exception to the rule that this melanomas are associated with an excellent prognosis. In this, as well as in other studies, after accounting for the effect on prognosis of tumor thickness, level has been shown to be a prognostic indicator with independent significance. The continued use of level as a prognostic indicator, in addition to thickness, is recommended.

Full text

PDF
98

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balch C. M., Murad T. M., Soong S. J., Ingalls A. L., Halpern N. B., Maddox W. A. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg. 1978 Dec;188(6):732–742. doi: 10.1097/00000658-197812000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balch C. M., Soong S. J., Milton G. W., Shaw H. M., McGovern V. J., Murad T. M., McCarthy W. H., Maddox W. A. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg. 1982 Dec;196(6):677–684. doi: 10.1097/00000658-198212001-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blois M. S., Sagebiel R. W., Abarbanel R. M., Caldwell T. M., Tuttle M. S. Malignant melanoma of the skin. I. The association of tumor depth and type, and patient sex, age, and site with survival. Cancer. 1983 Oct 1;52(7):1330–1341. doi: 10.1002/1097-0142(19831001)52:7<1330::aid-cncr2820520732>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  4. Blois M. S., Sagebiel R. W., Tuttle M. S., Caldwell T. M., Taylor H. W. Judging prognosis in malignant melanoma of the skin. A problem of inference over small data sets. Ann Surg. 1983 Aug;198(2):200–206. doi: 10.1097/00000658-198308000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902–908. doi: 10.1097/00000658-197011000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clark W. H., Jr, Ainsworth A. M., Bernardino E. A., Yang C. H., Mihm C. M., Jr, Reed R. J. The developmental biology of primary human malignant melanomas. Semin Oncol. 1975 Jun;2(2):83–103. [PubMed] [Google Scholar]
  7. Clark W. H., Jr, From L., Bernardino E. A., Mihm M. C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969 Mar;29(3):705–727. [PubMed] [Google Scholar]
  8. Day C. L., Jr, Mihm M. C., Jr, Sober A. J., Fitzpatrick T. B., Malt R. A. Narrower margins for clinical stage I malignant melanoma. N Engl J Med. 1982 Feb 25;306(8):479–482. doi: 10.1056/NEJM198202253060810. [DOI] [PubMed] [Google Scholar]
  9. Day C. L., Jr, Mihm M. C., Jr, Sober A. J., Harris M. N., Kopf A. W., Fitzpatrick T. B., Lew R. A., Harrist T. J., Golomb F. M., Postel A. Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg. 1982 Jan;195(1):30–34. doi: 10.1097/00000658-198201001-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eldh J., Boeryd B., Peterson L. E. Prognostic factors in cutaneous malignant melanoma in stage I. A clinical, morphological and multivariate analysis. Scand J Plast Reconstr Surg. 1978;12(3):243–255. doi: 10.3109/02844317809013000. [DOI] [PubMed] [Google Scholar]
  11. Larsen T. E., Little J. H., Orell S. R., Prade M. International pathologists congruence survey on quantitation of malignant melanoma. Pathology. 1980 Apr;12(2):245–253. doi: 10.3109/00313028009060079. [DOI] [PubMed] [Google Scholar]
  12. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  13. McGovern V. J., Shaw H. M., Milton G. W., Farago G. A. Prognostic significance of the histological features of malignant melanoma. Histopathology. 1979 Sep;3(5):385–393. doi: 10.1111/j.1365-2559.1979.tb03020.x. [DOI] [PubMed] [Google Scholar]
  14. McGovern V. J., Shaw H. M., Milton G. W. Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology. 1983 Sep;7(5):673–680. doi: 10.1111/j.1365-2559.1983.tb02279.x. [DOI] [PubMed] [Google Scholar]
  15. Milton G. W., Shaw H. M., McCarthy W. H., Pearson L., Balch C. M., Soong S. J. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg. 1982 Feb;69(2):108–111. doi: 10.1002/bjs.1800690217. [DOI] [PubMed] [Google Scholar]
  16. Prade M., Sancho-Garnier H., Cesarini J. P., Cochran A. Difficulties encountered in the application of Clark classification and the Breslow thickness measurement in cutaneous malignant melanoma. Int J Cancer. 1980 Aug;26(2):159–163. doi: 10.1002/ijc.2910260206. [DOI] [PubMed] [Google Scholar]
  17. Rampen F. Changing concepts in melanoma management. Br J Dermatol. 1981 Mar;104(3):341–348. doi: 10.1111/j.1365-2133.1981.tb00960.x. [DOI] [PubMed] [Google Scholar]
  18. Reintgen D. S., Cox E. B., McCarty K. S., Jr, Vollmer R. T., Seigler H. F. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg. 1983 Sep;198(3):379–385. doi: 10.1097/00000658-198309000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rushmer R. F., Buettner K. J., Short J. M., Odland G. F. The skin. Science. 1966 Oct 21;154(3747):343–348. doi: 10.1126/science.154.3747.343. [DOI] [PubMed] [Google Scholar]
  20. Schmoeckel C., Bockelbrink A., Bockelbrink H., Koutsis J., Braun-Falco O. Low- and high-risk malignant melanoma--I. Evaluation of clinical and histological prognosticators in 585 cases. Eur J Cancer Clin Oncol. 1983 Feb;19(2):227–235. doi: 10.1016/0277-5379(83)90421-2. [DOI] [PubMed] [Google Scholar]
  21. Suffin S. C., Waisman J., Clark W. H., Jr, Morton D. L. Comparison of the classification by microscopic level (stage) of malignant melanoma by three independent groups of pathologists. Cancer. 1977 Dec;40(6):3112–3114. doi: 10.1002/1097-0142(197712)40:6<3112::aid-cncr2820400654>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  22. Trau H., Kopf A. W., Rigel D. S., Levine J., Rogers G., Levenstein M., Bart R. S., Mintzis M. M., Friedman R. J. Regression in malignant melanoma. J Am Acad Dermatol. 1983 Mar;8(3):363–368. doi: 10.1016/s0190-9622(83)70040-x. [DOI] [PubMed] [Google Scholar]
  23. Woods J. E., Soule E. H., Creagan E. T. Metastasis and death in patients with thin melanomas (less than 0.76 mm). Ann Surg. 1983 Jul;198(1):63–64. doi: 10.1097/00000658-198307000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES